Ryan Specialty Group (RYAN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
12 Feb, 2026Market trends and industry dynamics
Increasing risk and complexity in the world is driving demand for specialty insurance solutions, with retail brokers seeking more holistic offerings from fewer, larger partners.
The excess & surplus (E&S) market is growing rapidly, now representing 26% of the commercial market, driven by factors like catastrophe losses, social inflation, cyber threats, and novel health risks.
Retail brokers are consolidating their wholesale broker panels, increasing the need for scale and sophistication among wholesalers.
Delegated underwriting authority is increasingly valued for its efficiency and ability to deliver specialized solutions.
The total addressable market for specialty and E&S insurance is expanding, with E&S premiums showing a 10.6% CAGR from 2000 to 2024.
Business model and value proposition
Provides specialty products and solutions for insurance brokers, agents, and carriers, focusing on complex and hard-to-place risks.
78% of premiums are placed in the E&S market, offering tailored coverage and flexibility not available in the admitted market.
Operates through wholesale brokerage, binding authority, and delegated underwriting management, with a diversified product and service platform.
Maintains strong relationships with over 30,000 retail brokers and is a preferred partner for carriers seeking access to specialized talent and distribution.
Attracts and retains top industry talent, with a 98% producer retention rate in 2024 and a strong focus on training and innovation.
Financial performance and growth
Achieved $3.0 billion in LTM total revenue as of September 30, 2025, with 24.2% YTD total revenue growth and 11.4% YTD organic revenue growth.
Demonstrated a history of double-digit organic growth and strong adjusted EBITDAC margins, reaching 32.4% in the latest period.
Operating cash flow and EBITDAC-to-cash flow conversion remain robust, supporting debt service, acquisitions, and reinvestment.
Increased quarterly dividend by 9% in February 2025, reflecting confidence in ongoing cash generation.
Net leverage stood at 3.4x as of September 30, 2025, with recent upgrades in credit ratings and stable outlooks from major agencies.
Latest events from Ryan Specialty Group
- Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing17 Mar 2026 - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing17 Mar 2026 - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 202527 Feb 2026 - Q2 revenue up 23% to $855.2M, net income up 5.6%, guidance lowered amid property headwinds.RYAN
Q2 202512 Feb 2026 - Q3 revenue up 25% and net income up 118.6%, with strong organic growth and margin pressures from investments.RYAN
Q3 202512 Feb 2026 - Revenue up 18.8%, net income up 40.8%, with margin and guidance both raised.RYAN
Q2 20242 Feb 2026 - Double-digit growth and margin expansion are fueled by E&S specialization, M&A, and innovation.RYAN
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Strategic acquisitions, leadership continuity, and E&S market growth drive future expansion.RYAN
2024 KBW Insurance Conference22 Jan 2026 - Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDA up 29.4% year-over-year.RYAN
Q3 202417 Jan 2026